Analyst downgrades: NTRI, ENDP, CXP, AVR and BIOF
Posted Oct 4th 2007 11:00AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Hansen Natural (HANS)
.gif)
MOST NOTEWORTHY: NutriSystem, Endo Pharmaceuticals, Corporate Express NV, Aventine Renewable Energy Holdings and BioFuel Energy were today's noteworthy downgrades:
- NutriSystem (NASDAQ: NTRI) was downgraded to Hold from Buy at Lazard and to Buy from Strong Buy at Broadpoint following its lowered Q3 guidance.
- Jefferies downgraded shares of Endo Pharmaceuticals (NASDAQ: ENDP) to Hold from Buy after Impax Laboratories (NASDAQ: IPXL) filed a Paragraph IV challenge against Opana ER yesterday to reflect the potential for a generic version of Opana ER arriving as early as 2010 and the possibility of a similar threat against Lidoderm.
- Corporate Express (NYSE: CXP) was downgraded to Hold from Buy at ING, as they believe the new CEO's long-term targets are overly ambitious.
- JP Morgan downgraded Aventine Renewable (NYSE: AVR) and BioFuel Energy (NASDAQ: BIOF) to Neutral from Overweight, citing weaker fundamentals in ethanol pricing.
OTHER DOWNGRADES:
Tags: analyst, aventine, avr, biof, biofuel, charlotte russe, CharlotteRusse, chic, corporate express, CorporateExpress, cxp, downgrade, endo, endp, hans, hansen, impax, ipxl, monolithic power, MonolithicPower, mpwr, national semi, NationalSemi, nsm, ntri, nutrisystem, wet seal, WetSeal, wtsla
Entrepreneur's Journal: Putting together a solid sales contract
The week in preview: Earnings from Walmart, Macy's, and other retailers
Six top trades for the rest of 2009
Reader Comments (Page 1 of 1)
10-04-2007 @ 11:50AM
Van said...
GM to upgraded to buy and the stocks will double by the end of the year from the present $35.00 to around $60.00........Toyota/Honda will fall slightly by December.....Goldman & Sachs has purchased GM stocks quietly for over 8 months and their own stocks will equate in higher yields withing 3 months themselves........